comprehensive -WSS

comprehensive

author：leisure time 2025-09-02 22:08:27 - browse：89

President Biden's White House announced the first 10 medicines that will be up first in its new drug price negotiation program. Anna Moneymaker/Getty Images

WASHINGTON — Medicare on Tuesday announced it will negotiate prices for 10 drugs, including major blood thinners and diabetes medications, in the first round of its negotiation program created in Democrats’ drug pricing reform law.

The drugs include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, Johnson & Johnson’s blood thinner Xarelto, Merck’s diabetes drug Januvia, AstraZeneca’s diabetes drug Farxiga, Novartis’ heart failure treatment Entresto, Amgen’s rheumatoid arthritis drug Enbrel, Johnson & Johnson and AbbVie’s blood cancer treatment Imbruvica, J&J’s anti-inflammatory medicine Stelara, and Novo Nordisk insulins that go by names including Fiasp and NovoLog.

The new prices will be announced on Sept. 1, 2024, and will go into effect on Jan. 1, 2026. The drugs were chosen from a list of 50 treatments that cost Medicare’s pharmacy drug benefit the most money. The selected medicines cost Medicare more than $50 billion and made up 20% of the Medicare program’s pharmacy drug costs over a one-year period, the Department of Health and Human Services said. (Read more here about the winners and losers of the selection.)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Sutter Health’s antitrust win overturned by appeals court

WSS

Walensky prepares to leave CDC — and Congress — behind

Structure Therapeutics oral GLP

Medicare Advantage's lean provider networks lead CMS complaints

Eli Lilly’s Zepbound improved liver scarring in mid

Tori Bowie and the unacceptable rates of Black maternal death

Take antibiotics after sex, CDC recommends for certain risk groups

entertainment

comprehensive

knowledge

Affirmative action in medical school literally saved lives

ASCO Daily Recap: CAR

After affirmative action ruling, medical educators look to 'holistic review'

Data don't support strong claims for Covid

BioMarin wins approval for gene therapy to treat hemophilia A

Take antibiotics after sex, CDC recommends for certain risk groups

George Santos makes 1st court appearance after pleading not guilty to 13 counts

STAT wants to know your pick for a great summer read or listen

Apple is now the first public company to be valued at $3 trillion

Heart attack and stroke risk calculators need revising

focus

Senators tussle over abortion against the backdrop of a presidential campaign

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

At least 13 dead in Texas as scorching temps continue

The most pressing bird flu mysteries scientists want answered

UnitedHealth CEO's Medicaid comments send insurer stocks diving

focus

knowledge

focus

focus